Halting the Oxford vaccine trial doesn't mean it's not safe – it shows they're following the right process
- Written by Nigel William Crawford, Associate Professor, Murdoch Children's Research Institute
ShutterstockOnly days after the federal government announced a A$1.7 billion vaccine deal to roll out COVID-19 vaccines to Australians in 2021, one of the two candidates has halted its phase 3 trials after a participant became ill.
The AZD1222 vaccine, considered one of the frontrunners in the global race for a COVID-19 vaccine, was developed by...





